Dostarlimab is yet to be tested in phase 3 clinical trials for colorectal cancer. It has been used only in 12 patients in a small phase 2 trial- that too in a subset of colorectal cancer patients with a specific gene defect (hence currently not being prescribed for colorectal cancer). So without a RCT it is impossible to tell whether it can completely cure the colorectal cancer or not
Answered2022-08-24 20:12:11
1/1 people found this helpful